Filing Details

Accession Number:
0001209191-18-030711
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-16 19:45:26
Reporting Period:
2018-05-14
Accepted Time:
2018-05-16 19:45:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1404644 Aquinox Pharmaceuticals Inc AQXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1278711 J Daniel Levitt C/O Aquinox Pharmaceuticals, Inc.
450 - 887 Great Northern Way
Vancouver A1 V5T 4T5
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-14 3,906 $10.56 3,906 No 4 M Direct
Common Stock Disposition 2018-05-14 3,906 $12.67 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-05-14 3,906 $0.00 3,906 $10.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-07-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.65 to $12.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set in this footnote.
  2. All the shares subject to the 3,906 share option were fully vested.